Prednisone Completed Phase 3 Trials for Alzheimer's Disease (AD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00000178Multicenter Trial of Prednisone in Alzheimer's Disease